Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Research Tools and Instruments - Category 1 (<$150,000)

McGill University

$114,488.00

DNA/RNA synthesizer for bioorganic and medicinal nucleic acid chemistry

FY 2009-10

Summary
The rational design of new therapies for human malignancies may be achieved by chemically synthesizing analogues of the natural nucleic acids (DNA and RNA). Several such analogues are being developed in our laboratory; for example, one of much interest to us is a close 'cousin' of RNA: arabinonucleic acid (ANA), which contains arabinose instead of ribose as its sugar ring. Other compounds have a "lasso" structure, the so-called "RNA lariats"; these are very curious molecules that form in the nucleus of every eukoryotic cell. By comparing these structures with respect to their chemical and biological properties that are fundamental to RNA's biological functions, we hope to be able to generate alternative nucleic acid structures that are able to "silence" genes that participate in disease progression (cancer, inflammation, etc). Therefore, a significant component of our research at McGill focuses on the development of nucleic acid "analogues" with improved therapeutic potential. It is our hope that the chemical modified nucleic acids we will develop are generally applicable and can be employed against a wide range of therapeutic gene targets. The "gene machine" (an automated DNA/RNA synthesizer) provided by this research grant allows preparation of many of these nucleic acid analogues simultaneously and at a scale that will permit systematic evaluation of their three-dimensional structure and biological activity. The instrument, like no other in the market, is capable of making 12 molecules in a single run, at a scale that provides several milligram quantities needed for structural and in vivo studies. Students (HQP) trained with this instrument will gain new insights into DNA/RNA structure and biology, and develop expertise in synthesis, analytical skills, and strategies to develop candidate molecules into useful drugs. This expertise will increase their ability to tackle challenging problems and, simultaneously, improve their value to employers in the areas of chemistry and medicinal chemistry.
Program
Research Tools and Instruments - Category 1 (<$150,000)
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
390040-2010
Name nom
Damha, Masad
Department département
Chemistry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2010
Award amount
114488
Program id
EQPEQ
Program nane en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
1
Application title
DNA/RNA synthesizer for bioorganic and medicinal nucleic acid chemistry
Keyword
NA
Application summary
The rational design of new therapies for human malignancies may be achieved by chemically synthesizing analogues of the natural nucleic acids (DNA and RNA). Several such analogues are being developed in our laboratory; for example, one of much interest to us is a close 'cousin' of RNA: arabinonucleic acid (ANA), which contains arabinose instead of ribose as its sugar ring. Other compounds have a "lasso" structure, the so-called "RNA lariats"; these are very curious molecules that form in the nucleus of every eukoryotic cell. By comparing these structures with respect to their chemical and biological properties that are fundamental to RNA's biological functions, we hope to be able to generate alternative nucleic acid structures that are able to "silence" genes that participate in disease progression (cancer, inflammation, etc). Therefore, a significant component of our research at McGill focuses on the development of nucleic acid "analogues" with improved therapeutic potential. It is our hope that the chemical modified nucleic acids we will develop are generally applicable and can be employed against a wide range of therapeutic gene targets. The "gene machine" (an automated DNA/RNA synthesizer) provided by this research grant allows preparation of many of these nucleic acid analogues simultaneously and at a scale that will permit systematic evaluation of their three-dimensional structure and biological activity. The instrument, like no other in the market, is capable of making 12 molecules in a single run, at a scale that provides several milligram quantities needed for structural and in vivo studies. Students (HQP) trained with this instrument will gain new insights into DNA/RNA structure and biology, and develop expertise in synthesis, analytical skills, and strategies to develop candidate molecules into useful drugs. This expertise will increase their ability to tackle challenging problems and, simultaneously, improve their value to employers in the areas of chemistry and medicinal chemistry.
McGill University - $114,488 Grant (2009-10) | Canada Spends